首页>Asia-Pacific journal of clinical oncology>Survival and cardiac toxicity in patients with HER2‐positive, metastatic breast cancer treated with trastuzumab in routine clinical practice
Survival and cardiac toxicity in patients with HER2‐positive, metastatic breast cancer treated with trastuzumab in routine clinical practice
作者单位：Liverpool Cancer Therapy CentreLiverpool,New South Wales,Australia[1]Crown Princess Mary Cancer CentreWestmead HospitalWestmead,New South Wales,Australia[2]NHMRC Clinical Trials CentreUniversity of SydneyCamperdown,New South Wales,Australia[3]Macarthur Cancer Therapy CentreCampbelltown,New South Wales,Australia[4]
换一批
